Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease glucosephosphate dehydrogenase deficiency
Comorbidity C0002871|anaemia
Sentences 8
PubMedID- 25885097 Being aware of primaquine inducing acute haemolytic anaemia, participants with g6pd deficiency were exempted from taking part in a study that used primaquine to radically clear malaria parasites [13].
PubMedID- 24502194 Clinically significant adverse events observed following the daily 15 mg dose during the mppt consisted of symptoms and signs of moderate haemolysis and anaemia which were associated with g6pd deficiency [29].
PubMedID- 24742291 Nevertheless, primaquine may cause haemolytic anaemia in individuals with glucose-6-phosphate dehydrogenase deficiency (g6pdd), a major bottleneck for its large-scale use[6,7].
PubMedID- 26303162 Background: primaquine is used to prevent plasmodium vivax relapse; however, it is not implemented in many malaria-endemic countries, including cambodia, for fear of precipitating primaquine-induced acute haemolytic anaemia in patients with glucose-6-phosphate dehydrogenase deficiency (g6pdd).
PubMedID- 22607348 Primaquine has been associated with acute haemolytic anaemia in patients with g6pd deficiency and, therefore, knowledge of the prevalence and geographical distribution of this inherited blood condition in p. vivax endemic areas is important [49].
PubMedID- 20175930 Higher doses of primaquine can cause haemolytic anaemia in individuals with g6pd deficiency, but the lower doses used in this programme are thought to be safe, based on extensive experience in malaria elimination campaigns in past decades.
PubMedID- 24117340 g6pd deficiency in babies with sca worsens anaemia and increases blood transfusion requirements in the first years of life.
PubMedID- 25234071 Acute haemolytic anaemia and myolysis due to g6pd deficiency.

Page: 1